Bellwether Report.com Looks Under the Microscope at Salix Pharmaceuticals Ltd.,.

0 Comments | M2 Presswire, August, 2006

M2 PRESSWIRE-8 August 2006-bellwetherreport.com: Bellwether Report.com Looks Under the Microscope at Salix Pharmaceuticals Ltd.,(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:08082006 The Bellwether Report Takes Notice of Salix Pharmaceuticals Ltd. (Nasdaq:PRGX) Salix Pharmaceuticals is going after its gut instincts.

Focusing on drugs for gastrointestinal diseases, the company purchases drug products that are nearing commercial viability. The firm's two marketed products are Colazal, which treats ulcerative colitis, and Azasan, which suppresses the immune systems of organ transplant recipients. Colazal and Azasan were acquired from Biorex Laboratories and aaiPharma, respectively. Salix's Xifaxan, an antibiotic intended to prevent travelers' diarrhea, was...

Read the rest of this article with a Free Trial at HighBeam Research.
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)